ArticleBMC cancer2024

First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors.

Ye Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.